Wednesday, June 17, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 13 of 1,261
  1. US 12419888

    Methods of treating elevated plasma cholesterol

    INSTITUT DE CARDIOLOGIE DE MONTREAL · Granted Sep 23, 2025 · Expires Sep 18, 2045

    granted
  2. US 12419866

    Compounds and methods for treating an epileptic disorder

    The Regents of the University of California · Granted Sep 23, 2025 · Expires Sep 18, 2045

    granted
  3. US 12421251

    Cystic fibrosis transmembrane conductance regulator modulating agents

    Vertex Pharmaceuticals Incorporated · Granted Sep 23, 2025 · Expires Sep 18, 2045

    granted
  4. US 12419942

    Use of the Salmonella spp type III secretion proteins as a protective vaccination

    The Board of Regents for Oklahoma State University · Granted Sep 23, 2025 · Expires Sep 18, 2045

    granted
  5. US 12419895

    Methods for treating subjects with Prader-Willi syndrome

    ESSENTIALIS, INC. · Granted Sep 23, 2025 · Expires Sep 18, 2045

    granted
  6. US 12421188

    Heterocyclic compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Sep 23, 2025 · Expires Sep 18, 2045

    granted
  7. US 12420085

    Synergistic therapies for inter vertebral disc degeneration

    Discure Technologies Ltd · Granted Sep 23, 2025 · Expires Sep 18, 2045

    granted
  8. US 12419958

    Clinical formulations

    Astellas Institute for Regenerative Medicine · Granted Sep 23, 2025 · Expires Sep 18, 2045

    granted
  9. US 2025290040

    GAMMA DELTA T CELL COMPOSITIONS AND METHODS OF USE

    BEIGENE SWITZERLAND GMBH [CH] · Granted Sep 18, 2025 · Expires Sep 13, 2045

    granted
  10. US 12415995

    Bacterial toxins and uses thereof as Ras specific proteases for treating cell proliferation diseases and disorders

    Northwestern University · Granted Sep 16, 2025 · Expires Sep 11, 2045

    granted
  11. US 12415867

    Anti-DCLK1 antibodies and chimeric antigen receptors, and compositions and methods of use thereof

    The Board of Regents of the University of Oklahoma · Granted Sep 16, 2025 · Expires Sep 11, 2045

    granted
  12. US 12416008

    Compositions and methods of use for small-molecule regulation of CRISPR-Cas9 activity using RNA aptamers

    The Regents of the University of Colorado, a Body Corporate · Granted Sep 16, 2025 · Expires Sep 11, 2045

    granted
  13. US 12416006

    Cell death-inducing DFFA-like effector B (CIDEB) iRNA compositions and methods of use thereof

    Alnylam Pharmaceuticals, Inc. · Granted Sep 16, 2025 · Expires Sep 11, 2045

    granted
  14. US 12414911

    Topical compositions and methods of use

    MIRACLE FRUIT OIL L.L.C. · Granted Sep 16, 2025 · Expires Sep 11, 2045

    granted
  15. US 12415794

    Pyridazinone compounds and uses thereof

    EDGEWISE THERAPEUTICS, INC. · Granted Sep 16, 2025 · Expires Sep 11, 2045

    granted
  16. US 12414907

    Peptide having hair growth promoting activity and use thereof

    CAREGEN CO., LTD. · Granted Sep 16, 2025 · Expires Sep 11, 2045

    granted
  17. US 12414953

    Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)

    Prelude Therapeutics, Incorporated · Granted Sep 16, 2025 · Expires Sep 11, 2045

    granted
  18. US 12415779

    Processes of making 3-fluoro-5-(((1S,2aR)-1,3,3,4,4-pentafluoro-2a-hydroxy-2,2a,3,4-tetrahydro-1H-cyclopenta[cd]inden-7-yl)oxy)-benzonitrile and polymorphs thereof

    NIKANG THERAPEUTICS, INC. · Granted Sep 16, 2025 · Expires Sep 11, 2045

    granted
  19. US 12414934

    Combination therapies

    Aardvark Therapeutics, Inc. · Granted Sep 16, 2025 · Expires Sep 11, 2045

    granted
  20. US 12415854

    Antibodies to TIGIT

    Arcus Biosciences, Inc. · Granted Sep 16, 2025 · Expires Sep 11, 2045

    granted
  21. US 12415856

    EGFR x CD28 multispecific antibodies

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 16, 2025 · Expires Sep 11, 2045

    granted
  22. US 12415861

    Anti C-MET antibodies

    CENTESSA PHARMACEUTICALS (UK) LIMITED · Granted Sep 16, 2025 · Expires Sep 11, 2045

    granted
  23. US 12414999

    Compositions and methods relating to macrophages and/or monocytes with adhered particles

    The Regents of the University of California · Granted Sep 16, 2025 · Expires Sep 11, 2045

    granted
  24. US 12415863

    Compositions and methods for treating cancer

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Sep 16, 2025 · Expires Sep 11, 2045

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.